Orbimed Advisors as of June 30, 2017
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 135 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alexion Pharmaceuticals | 4.9 | $471M | 3.9M | 121.67 | |
| Celgene Corporation | 4.7 | $445M | 3.4M | 129.87 | |
| Biogen Idec (BIIB) | 4.6 | $442M | 1.6M | 271.36 | |
| Boston Scientific Corporation (BSX) | 4.2 | $399M | 14M | 27.72 | |
| Merck & Co (MRK) | 3.7 | $352M | 5.5M | 64.09 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.7 | $261M | 2.0M | 128.87 | |
| Eli Lilly & Co. (LLY) | 2.6 | $253M | 3.1M | 82.30 | |
| Wright Medical Group Nv | 2.6 | $246M | 8.9M | 27.49 | |
| Regeneron Pharmaceuticals (REGN) | 2.4 | $229M | 467k | 491.14 | |
| Agilent Technologies Inc C ommon (A) | 2.4 | $226M | 3.8M | 59.31 | |
| Amgen (AMGN) | 2.4 | $224M | 1.3M | 172.23 | |
| Edwards Lifesciences (EW) | 2.3 | $218M | 1.8M | 118.24 | |
| Puma Biotechnology (PBYI) | 2.2 | $212M | 2.4M | 87.40 | |
| Incyte Corporation (INCY) | 2.2 | $209M | 1.7M | 125.91 | |
| CIGNA Corporation | 2.1 | $205M | 1.2M | 167.39 | |
| Clovis Oncology | 2.1 | $197M | 2.1M | 93.63 | |
| Humana (HUM) | 1.9 | $186M | 771k | 240.62 | |
| Anthem (ELV) | 1.8 | $173M | 921k | 188.13 | |
| Abbvie (ABBV) | 1.7 | $159M | 2.2M | 72.51 | |
| Johnson & Johnson (JNJ) | 1.6 | $149M | 1.1M | 132.29 | |
| Gilead Sciences (GILD) | 1.5 | $147M | 2.1M | 70.78 | |
| Loxo Oncology | 1.4 | $139M | 1.7M | 80.19 | |
| Aetna | 1.4 | $135M | 888k | 151.83 | |
| Array BioPharma | 1.2 | $119M | 14M | 8.37 | |
| Mylan Nv | 1.2 | $116M | 3.0M | 38.82 | |
| Ironwood Pharmaceuticals (IRWD) | 1.1 | $109M | 5.8M | 18.88 | |
| Intercept Pharmaceuticals In | 1.1 | $104M | 857k | 121.07 | |
| Jazz Pharmaceuticals (JAZZ) | 1.1 | $100M | 646k | 155.50 | |
| Aerie Pharmaceuticals | 1.0 | $96M | 1.8M | 52.55 | |
| Synergy Pharmaceuticals | 1.0 | $94M | 21M | 4.45 | |
| Thermo Fisher Scientific (TMO) | 1.0 | $93M | 534k | 174.47 | |
| Ascendis Pharma A S (ASND) | 1.0 | $94M | 3.4M | 27.76 | |
| Audentes Therapeutics | 1.0 | $92M | 4.8M | 19.13 | |
| Shire | 0.9 | $91M | 549k | 165.27 | |
| Allergan | 0.9 | $91M | 374k | 243.09 | |
| BioMarin Pharmaceutical (BMRN) | 0.9 | $89M | 983k | 90.82 | |
| Magellan Health Services | 0.9 | $89M | 1.2M | 72.90 | |
| Pfizer (PFE) | 0.9 | $83M | 2.5M | 33.59 | |
| UnitedHealth (UNH) | 0.8 | $80M | 429k | 185.42 | |
| Insys Therapeutics | 0.8 | $78M | 6.2M | 12.65 | |
| Medtronic (MDT) | 0.8 | $78M | 879k | 88.75 | |
| Allergan Plc pfd conv ser a | 0.8 | $77M | 88k | 867.41 | |
| Insmed (INSM) | 0.8 | $75M | 4.4M | 17.16 | |
| Mallinckrodt Pub | 0.8 | $75M | 1.7M | 44.81 | |
| Glaukos (GKOS) | 0.8 | $72M | 1.7M | 41.47 | |
| Illumina (ILMN) | 0.7 | $69M | 399k | 173.52 | |
| Corvus Pharmaceuticals (CRVS) | 0.7 | $65M | 5.4M | 12.10 | |
| Viewray (VRAYQ) | 0.6 | $61M | 9.5M | 6.47 | |
| Achillion Pharmaceuticals | 0.6 | $60M | 13M | 4.59 | |
| Global Blood Therapeutics In | 0.6 | $59M | 2.2M | 27.35 | |
| Beigene (ONC) | 0.6 | $58M | 1.3M | 45.00 | |
| Select Medical Holdings Corporation (SEM) | 0.6 | $57M | 3.7M | 15.35 | |
| Gw Pharmaceuticals Plc ads | 0.6 | $56M | 561k | 100.25 | |
| Immunomedics Inc note 4.750% 2/1 | 0.6 | $55M | 30M | 1.83 | |
| Hca Holdings (HCA) | 0.6 | $52M | 597k | 87.20 | |
| Alnylam Pharmaceuticals (ALNY) | 0.5 | $51M | 639k | 79.76 | |
| Bristol Myers Squibb (BMY) | 0.5 | $49M | 875k | 55.72 | |
| Intuitive Surgical (ISRG) | 0.5 | $45M | 48k | 935.37 | |
| Stryker Corporation (SYK) | 0.5 | $44M | 316k | 138.78 | |
| Immunomedics | 0.5 | $44M | 4.9M | 8.83 | |
| Intellia Therapeutics (NTLA) | 0.5 | $43M | 2.7M | 16.00 | |
| Bluebird Bio | 0.4 | $42M | 400k | 105.05 | |
| Dermira | 0.4 | $41M | 1.4M | 29.14 | |
| Nabriva Therapeutics | 0.4 | $41M | 3.9M | 10.48 | |
| Nevro (NVRO) | 0.4 | $39M | 526k | 74.43 | |
| Pieris Pharmaceuticals | 0.4 | $37M | 7.3M | 5.06 | |
| Selecta Biosciences | 0.4 | $37M | 1.8M | 19.86 | |
| Envision Healthcare | 0.4 | $36M | 578k | 62.67 | |
| Momenta Pharmaceuticals | 0.4 | $36M | 2.1M | 16.90 | |
| eHealth (EHTH) | 0.4 | $35M | 1.8M | 18.80 | |
| Radius Health | 0.3 | $32M | 704k | 45.23 | |
| Otonomy | 0.3 | $29M | 1.6M | 18.85 | |
| ImmunoGen | 0.3 | $28M | 3.9M | 7.11 | |
| Juno Therapeutics | 0.3 | $27M | 915k | 29.89 | |
| Steadymed | 0.3 | $27M | 4.2M | 6.30 | |
| Iovance Biotherapeutics (IOVA) | 0.3 | $25M | 3.4M | 7.45 | |
| Integra LifeSciences Holdings (IART) | 0.2 | $23M | 427k | 54.51 | |
| Galapagos Nv- (GLPG) | 0.2 | $22M | 284k | 76.52 | |
| Obseva Sa | 0.2 | $22M | 2.6M | 8.55 | |
| Sinovac Biotech | 0.2 | $18M | 2.7M | 6.75 | |
| Assembly Biosciences | 0.2 | $18M | 888k | 20.65 | |
| Dbv Technologies S A | 0.2 | $18M | 513k | 35.71 | |
| Immunogen Inc bond | 0.2 | $18M | 10M | 1.83 | |
| Teva Pharmaceutical Industries (TEVA) | 0.2 | $18M | 526k | 33.22 | |
| Vanda Pharmaceuticals (VNDA) | 0.2 | $16M | 968k | 16.30 | |
| Xencor (XNCR) | 0.2 | $16M | 747k | 21.11 | |
| Cti Biopharma | 0.2 | $17M | 5.0M | 3.31 | |
| Coherus Biosciences (CHRS) | 0.2 | $16M | 1.1M | 14.35 | |
| Novus Therapeutics | 0.2 | $15M | 2.5M | 5.85 | |
| Natera (NTRA) | 0.1 | $14M | 1.3M | 10.86 | |
| Neurocrine Biosciences (NBIX) | 0.1 | $13M | 285k | 46.00 | |
| Newlink Genetics Corporation | 0.1 | $14M | 1.8M | 7.35 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $12M | 2.3M | 5.20 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.1 | $12M | 15M | 0.82 | |
| Wright Medical Group Rtsn V | 0.1 | $13M | 8.7M | 1.46 | |
| Aurinia Pharmaceuticals (AUPH) | 0.1 | $11M | 1.8M | 6.13 | |
| Argenx Se (ARGX) | 0.1 | $11M | 500k | 21.21 | |
| AstraZeneca (AZN) | 0.1 | $8.5M | 250k | 34.09 | |
| Alkermes (ALKS) | 0.1 | $8.4M | 145k | 57.97 | |
| Heron Therapeutics (HRTX) | 0.1 | $9.0M | 650k | 13.85 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $8.6M | 1.9M | 4.49 | |
| Dimension Therapeutics | 0.1 | $7.8M | 5.4M | 1.45 | |
| Verona Pharma Plc ads (VRNA) | 0.1 | $7.8M | 667k | 11.66 | |
| Zimmer Holdings (ZBH) | 0.1 | $6.3M | 49k | 128.41 | |
| D Fluidigm Corp Del (LAB) | 0.1 | $7.1M | 1.7M | 4.04 | |
| Fluidigm Corporation convertible cor | 0.1 | $6.3M | 10M | 0.63 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $6.1M | 437k | 13.97 | |
| Aeglea Biotherapeutics | 0.1 | $5.7M | 1.5M | 3.85 | |
| Crispr Therapeutics (CRSP) | 0.1 | $6.0M | 372k | 16.02 | |
| NuVasive | 0.1 | $5.0M | 66k | 76.92 | |
| Halozyme Therapeutics (HALO) | 0.1 | $4.5M | 350k | 12.82 | |
| Infinity Pharmaceuticals (INFIQ) | 0.1 | $5.1M | 3.3M | 1.57 | |
| Redhill Biopharma Ltd cmn | 0.1 | $4.9M | 565k | 8.62 | |
| Sientra | 0.1 | $4.7M | 483k | 9.72 | |
| Invitae (NVTAQ) | 0.1 | $4.4M | 457k | 9.56 | |
| Sierra Oncology | 0.1 | $4.3M | 3.7M | 1.17 | |
| Valeant Pharmaceuticals Int | 0.0 | $3.4M | 195k | 17.30 | |
| Tesaro | 0.0 | $4.2M | 30k | 139.86 | |
| Glycomimetics | 0.0 | $3.8M | 338k | 11.16 | |
| Affimed Therapeutics B V | 0.0 | $3.7M | 1.8M | 2.05 | |
| Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.0 | $4.3M | 7.0M | 0.61 | |
| Minerva Neurosciences | 0.0 | $3.0M | 344k | 8.85 | |
| Orexigen Therapeutics Inc note 2.750%12/0 | 0.0 | $2.4M | 5.2M | 0.47 | |
| Xenon Pharmaceuticals (XENE) | 0.0 | $2.0M | 635k | 3.15 | |
| Cellectis S A (CLLS) | 0.0 | $1.7M | 67k | 25.82 | |
| Roka Bioscience | 0.0 | $2.3M | 894k | 2.58 | |
| Amarin Corporation | 0.0 | $826k | 205k | 4.03 | |
| Biolinerx Ltd-spons | 0.0 | $883k | 1.0M | 0.85 | |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.0 | $555k | 500k | 1.11 | |
| Biomarin Pharmaceutical Inc note 1.500%10/1 | 0.0 | $600k | 500k | 1.20 | |
| Marinus Pharmaceuticals | 0.0 | $778k | 568k | 1.37 | |
| Noveliontherapeuti.. | 0.0 | $923k | 100k | 9.23 | |
| Alimera Sciences | 0.0 | $348k | 250k | 1.39 | |
| Xtant Med Holdings | 0.0 | $314k | 475k | 0.66 | |
| Medigus Ltd sponsord | 0.0 | $131k | 60k | 2.18 |
